The Patent Finder

Macrocyclic Inhibitors of Flaviviridae Viruses

Selcia Limited

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,062,092Macrocyclic Inhibitors of Flaviviridae Viruses
In force
 · High confidence
Cypralis LimitedIn force
High confidence
US 9,642,889Macrocyclic Inhibitors of Flaviviridae Viruses
In force
 · Medium confidence
Cypralis LimitedIn force
Medium confidence
US 10,472,392Macrocyclic Inhibitors of Flaviviridae Viruses
In force
 · Medium confidence
Cypralis LimitedIn force
Medium confidence
Application 15/094,777Macrocyclic Inhibitors of Flaviviridae Viruses
Abandoned
Abandoned Apr 13, 2017
Cypralis LimitedAbandonedAbandoned Apr 13, 2017
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Selcia Limited.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited